Peptos
About
Listed competitors
Also in this space
Shares AI-Driven Protein Design, Drug Discovery
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Shares Biotech, HealthTech
AI-driven drug discovery platform accelerating breakthrough scientific research.
Shares Drug Discovery, Generative AI
AI-powered platform for designing novel molecular structures for new medicines.
Shares Biotech, Drug Discovery
AI-driven drug discovery platform for rapid development of novel therapeutics.
Shares Biotech, Drug Discovery
Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
Shares Drug Discovery, Biotech
Key facts
- Website
- peptos.ai
- Total funding
- $4M (Seed)
- Business model
- B2B
Funding rounds
Test your Agent Readiness
How well ChatGPT, Claude and the other agents can read and use a site. About a minute.
Frequently asked
Is Peptos trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Peptos is 52 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Peptos raised?
Peptos has raised a total of $4M in funding. The most recent round on record is Seed.
A tool we built
API and MCP Security Scanner
See what an API or MCP server gives a stranger: transport, auth, CORS, rate limits, and which tools answer with no credentials. Use it before you publish an endpoint.
Need it connected to Peptos or your own stack? Ask for a custom integration. We reply within 2 days.
SEC filings, insider activity, nonprofit links and pay benchmarks for Peptos:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

